Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.8 GBX | -0.37% | +3.64% | -7.53% |
Apr. 12 | JPMorgan raises Taylor Wimpey, Persimmon | AN |
Mar. 12 | Target Healthcare interim net asset value and contractual rent grow | AN |
Valuation
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 445.2 | 503.2 | 590.3 | 672.3 | 445.3 | 494.9 | - | - |
Enterprise Value (EV) 1 | 445.2 | 616.9 | 697.1 | 869.2 | 657 | 725.9 | 751.1 | 775.5 |
P/E ratio | 14.3 x | 15.3 x | 12.5 x | 13.2 x | -67.7 x | 7.6 x | 7.58 x | 6.6 x |
Yield | 5.69% | 6.07% | 5.82% | 6.24% | 8.61% | 7.14% | 7.31% | 7.52% |
Capitalization / Revenue | 13 x | 11.4 x | 11.8 x | 10.5 x | 6.57 x | 6.93 x | 6.76 x | 6.56 x |
EV / Revenue | 13 x | 13.9 x | 13.9 x | 13.6 x | 9.7 x | 10.2 x | 10.3 x | 10.3 x |
EV / EBITDA | - | 21.5 x | - | 17.3 x | 11.5 x | 12 x | 12.5 x | 12.5 x |
EV / FCF | - | -6,424,227 x | - | - | - | - | - | - |
FCF Yield | - | -0% | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 385,089 | 457,488 | 511,542 | 620,237 | 620,237 | 620,237 | - | - |
Reference price 2 | 1.156 | 1.100 | 1.154 | 1.084 | 0.7180 | 0.7980 | 0.7980 | 0.7980 |
Announcement Date | 9/17/19 | 10/6/20 | 10/20/21 | 10/12/22 | 10/10/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 34.28 | 44.27 | 49.98 | 63.86 | 67.75 | 71.4 | 73.17 | 75.4 |
EBITDA 1 | - | 28.64 | - | 50.16 | 57.01 | 60.5 | 59.9 | 61.9 |
EBIT 1 | - | 37.04 | 49.6 | 55.7 | 3.564 | 60.2 | 66.4 | 64.9 |
Operating Margin | - | 83.67% | 99.24% | 87.23% | 5.26% | 84.31% | 90.75% | 86.07% |
Earnings before Tax (EBT) 1 | - | 31.62 | 43.88 | 49.1 | -6.572 | 64.45 | 59.27 | 74.45 |
Net income 1 | - | 31.62 | 43.88 | 49.1 | -6.572 | 64.45 | 65.3 | 74.45 |
Net margin | - | 71.43% | 87.8% | 76.88% | -9.7% | 90.27% | 89.25% | 98.74% |
EPS 2 | 0.0810 | 0.0718 | 0.0923 | 0.0820 | -0.0106 | 0.1050 | 0.1052 | 0.1210 |
Free Cash Flow | - | -96.03 | - | - | - | - | - | - |
FCF margin | - | -216.94% | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share 2 | 0.0658 | 0.0668 | 0.0672 | 0.0676 | 0.0618 | 0.0570 | 0.0583 | 0.0600 |
Announcement Date | 9/17/19 | 10/6/20 | 10/20/21 | 10/12/22 | 10/10/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2022 Q1 | 2023 S1 | 2024 S1 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | - | - |
EBIT | - | - | - |
Operating Margin | - | - | - |
Earnings before Tax (EBT) | - | - | - |
Net income | - | -34.18 | - |
Net margin | - | - | - |
EPS | - | -0.0551 | - |
Dividend per Share 1 | 0.0200 | - | 0.0286 |
Announcement Date | 1/12/22 | 3/27/23 | 3/12/24 |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | 114 | 107 | 197 | 212 | 231 | 256 | 281 |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 3.97 x | - | 3.926 x | 3.713 x | 3.817 x | 4.277 x | 4.532 x |
Free Cash Flow | - | -96 | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | 5.12% | 4.9% | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 99.6 | 118 | 51.4 | 207 | 29.3 | 42.2 | 7.7 | - |
Capex / Sales | 290.62% | 265.44% | 102.84% | 324.14% | 43.31% | 59.1% | 10.52% | - |
Announcement Date | 9/17/19 | 10/6/20 | 10/20/21 | 10/12/22 | 10/10/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.53% | 621M | |
+2.99% | 27.38B | |
+7.77% | 24.98B | |
+0.82% | 21.07B | |
+0.96% | 16.07B | |
-1.09% | 15.52B | |
-0.56% | 13.1B | |
-0.16% | 12.59B | |
-10.22% | 11.81B | |
+5.92% | 11.44B |
- Stock Market
- Equities
- THRL Stock
- Financials Target Healthcare REIT PLC